bioMerieux acquires microbial genotyping technology

By Elaine Rigoli

Tampa, Fla., Sept. 18 - bioMerieux has acquired Bacterial Barcodes, Inc., a molecular biotechnology company based in Athens, Ga., which developed and markets DiversiLab, a patented system dedicated to the field of automated microbial genotyping, offering solutions to track hospital-acquired infections and for environmental control for product safety.

The German diagnostics group said DiversiLab technology automates the previously cumbersome method of strain typing and allows for better genotypic characterization of bacteria, yeast and molds, which helps identify the source and stop the spread of further infection.

"The addition of this innovative and timely solution to bioMerieux's technology portfolio is perfectly aligned with the company's strategic commitment to focus on infectious diseases, as well as on industrial applications. It will advance bioMerieux's rapid growth in the field of molecular biology," president and chief executive officer Eric Bouvier said in a news release.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.